All Indian children aged 12 or older will become eligible for COVID-19 vaccinations from next month, when drug maker Cadila Healthcare launches its ZyCoV-D product, Reuters reported, citing sources with direct knowledge of the matter.

The world's first DNA-based COVID-19 vaccine, ZyCoV-D won emergency authorization from Indian regulators last month. From October, the company, better known as Zydus Cadila, will produce 10 million doses a month.